Bear bile powder attenuates senecionine-induced hepatic sinusoidal obstruction syndrome in mice. 2022

Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
The MOE Key Laboratory for Standardization of Chinese Medicines and the SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shanghai R & D Center for Standardization of Traditional Chinese Medicines, Shanghai 201203, China.

Hepatic sinusoidal obstruction syndrome (HSOS) via exposure to pyrrolizidine alkaloids (PAs) is with high mortality and there is no effective treatment in clinics. Bear bile powder (BBP) is a famous traditional animal drug for curing a variety of hepatobiliary diseases such as cholestasis, inflammation, and fibrosis. Here, we aim to evaluate the protective effect of BBP against HSOS induced by senecionine, a highly hepatotoxic PA compound. Our results showed that BBP treatment protected mice from senecionine-induced HSOS dose-dependently, which was evident by improved liver histology including reduced infiltration of inflammatory cells and collagen positive cells, alleviated intrahepatic hemorrhage and hepatic sinusoidal endothelial cells, as well as decreased conventional serum liver function indicators. In addition, BBP treatment lowered matrix metalloproteinase 9 and pyrrole-protein adducts, two well-known markers positively associated with the severity of PA-induced HSOS. Further investigation showed that BBP treatment prevents the development of liver fibrosis by decreasing transforming growth factor beta and downstream fibrotic molecules. BBP treatment also alleviated senecionine-induced liver inflammation and lowered the pro-inflammatory cytokines, in which tauroursodeoxycholic acid played an important role. What's more, BBP treatment also decreased the accumulation of hydrophobic bile acids, such as cholic acid, taurocholic acid, glycocholic acid, as well. We concluded that BBP attenuates senecionine-induced HSOS in mice by repairing the bile acids homeostasis, preventing liver fibrosis, and alleviating liver inflammation. Our present study helps to pave the way to therapeutic approaches of the treatment of PA-induced liver injury in clinics.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D011763 Pyrrolizidine Alkaloids A group of ALKALOIDS, characterized by a nitrogen-containing necine, occurring mainly in plants of the BORAGINACEAE; COMPOSITAE; and LEGUMINOSAE plant families. They can be activated in the liver by hydrolysis of the ester and desaturation of the necine base to reactive electrophilic pyrrolic CYTOTOXINS. Pyrrolizidine Alkaloid,Senecio Alkaloid,Senecio Alkaloids,Alkaloid, Pyrrolizidine,Alkaloid, Senecio,Alkaloids, Pyrrolizidine,Alkaloids, Senecio
D006504 Hepatic Veno-Occlusive Disease Liver disease that is caused by injuries to the ENDOTHELIAL CELLS of the vessels and subendothelial EDEMA, but not by THROMBOSIS. Extracellular matrix, rich in FIBRONECTINS, is usually deposited around the HEPATIC VEINS leading to venous outflow occlusion and sinusoidal obstruction. Sinusoidal Obstruction Syndrome,Veno-Occlusive Disease, Hepatic,Hepatic Veno Occlusive Disease,Disease, Hepatic Veno-Occlusive,Hepatic Veno-Occlusive Diseases,Syndrome, Sinusoidal Obstruction,Veno Occlusive Disease, Hepatic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001503 Ursidae The family of carnivorous or omnivorous bears, having massive bodies, coarse heavy fur, relatively short limbs, and almost rudimentary tails. Ailuropoda,Bears,Black Bears,Giant Pandas,Grizzly Bears,Pandas, Giant,Pandas, Greater,Polar Bears,Spectacled Bear,Tremarctos,Ursus,Bear,Bear, Black,Bear, Grizzly,Bear, Polar,Bear, Spectacled,Bears, Black,Bears, Grizzly,Bears, Polar,Bears, Spectacled,Black Bear,Giant Panda,Greater Panda,Greater Pandas,Grizzly Bear,Panda, Giant,Panda, Greater,Polar Bear,Spectacled Bears
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell

Related Publications

Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
August 2021, Toxicology,
Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
August 2018, Medicina clinica,
Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
January 2018, In vivo (Athens, Greece),
Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
March 2023, Liver international : official journal of the International Association for the Study of the Liver,
Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
September 2023, Journal of biochemical and molecular toxicology,
Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
January 2013, Current medicinal chemistry,
Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
August 2017, Clinical lymphoma, myeloma & leukemia,
Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
April 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
November 2022, Molecular medicine reports,
Kai-Yuan Jiang, and Yi Zhang, and Xuan-Ling Ye, and Fen Xiong, and Yan Chen, and Xia-Li Jia, and Yi-Xin Zhang, and Li Yang, and Ai-Zhen Xiong, and Zheng-Tao Wang
March 2014, Journal of digestive diseases,
Copied contents to your clipboard!